Jackson C R, Vavro C L, Valentine M E, Pennington K N, Lanier E R, Katz S L, Diliberti J H, McKinney R E, Wilfert C M, St Clair M H
Duke University Medical Center, Durham, NC, USA.
Pediatr Infect Dis J. 1997 Feb;16(2):200-4. doi: 10.1097/00006454-199702000-00007.
We evaluated the responses of HIV-infected children to a single dose of split-virus influenza vaccine and the relationship to viral load and other characteristics.
Fifty-three HIV-infected children ages 1.8 to 13.2 years were given influenza vaccine for the 1994 to 1995 influenza season (Wyeth-Ayerst: A/Texas H1N1, A/Shangdong H3N2 and B/Panama). Immunologic and virologic factors were assessed at the time of and 2 to 10 weeks after immunization.
The differences between pre- and postimmunization CD4+ counts, CD4+:CD8+ ratios and viral load were not significant. Thirty-one of 53 children (58.4%) had a > 2-fold increase and 16 of 53 (30%) had a 4-fold rise in their postimmunization antibody titers for at least one component of the vaccine. Influenza immunization in the 1993 to 1994 flu season and administration of intravenous immunoglobulin around the time of immunization was not associated with immune response to the vaccine. Factors that were negatively associated with antibody response included increased time between samples (P = 0.004) and decreased preimmunization CD4+:CD8+ ratio (P = 0.02).
Influenza immunization in this population is safe, and a positive antibody response to influenza immunization is not associated with significant clinical events or change in HIV-1 plasma viral burden.
我们评估了感染人类免疫缺陷病毒(HIV)的儿童对单剂量裂解病毒流感疫苗的反应,以及其与病毒载量和其他特征的关系。
53名年龄在1.8至13.2岁之间的HIV感染儿童接种了1994至1995流感季节的流感疫苗(惠氏-艾尔斯特公司生产:甲型/得克萨斯H1N1、甲型/山东H3N2和乙型/巴拿马)。在免疫接种时以及接种后2至10周评估免疫和病毒学因素。
免疫接种前后的CD4 +细胞计数、CD4 +:CD8 +比值和病毒载量差异不显著。53名儿童中有31名(58.4%)至少对一种疫苗成分的免疫接种后抗体滴度增加了2倍以上,53名中有16名(30%)增加了4倍。1993至1994流感季节的流感免疫接种以及免疫接种前后静脉注射免疫球蛋白与疫苗的免疫反应无关。与抗体反应呈负相关的因素包括样本采集间隔时间增加(P = 0.004)和免疫接种前CD4 +:CD8 +比值降低(P = 0.02)。
该人群的流感免疫接种是安全的,对流感免疫接种的阳性抗体反应与重大临床事件或HIV-1血浆病毒载量变化无关。